Nyxoah SA (EBR:NYXH)

Belgium flag Belgium · Delayed Price · Currency is EUR
5.38
-0.24 (-4.27%)
At close: Apr 24, 2025, 5:30 PM CET
-45.10%
Market Cap 201.36M
Revenue (ttm) 4.52M
Net Income (ttm) -59.24M
Shares Out 37.43M
EPS (ttm) -1.81
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 92,266
Average Volume 155,434
Open 5.65
Previous Close 5.62
Day's Range 5.32 - 5.75
52-Week Range 5.04 - 11.40
Beta 0.65
RSI 31.92
Earnings Date May 13, 2025

About Nyxoah

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium. [Read more]

Sector Healthcare
Founded 2009
Employees 184
Stock Exchange Euronext Brussels
Ticker Symbol NYXH
Full Company Profile

Financial Performance

In 2024, Nyxoah's revenue was 4.52 million, an increase of 3.98% compared to the previous year's 4.35 million. Losses were -59.24 million, 37.1% more than in 2023.

Financial Statements

News

There is no news available yet.